Global inflation worries, mixed growth signals and shifting bond markets are pushing many investors to look for sturdier building blocks in their portfolios. That is where the Low-Risk Leaders screener comes in. It focuses on companies with strong balance sheets and the lowest risk scores in the model, designed to help you dial down volatility without walking away from potential returns. In this article, you will see three stocks from this screener that illustrate how resilient businesses can help anchor a portfolio when headlines are noisy and economic signals pull in different directions.

Hecla Mining (HL)

Overview: Hecla Mining is a long-established precious and base metals producer that mines silver, gold, lead and zinc in North America and sells concentrates, carbon material and unrefined doré to smelters, metal traders and processors around the world.

Operations: Hecla generates most of its revenue from its Greens Creek mine at about US$745.7m, Lucky Friday at about US$352.8m, Keno Hill at about US$181.6m, with smaller contributions from Other at about US$36.7m and various segment adjustments and intersegment eliminations.

Market Cap: US$11.52b

Hecla Mining stands out in a low risk screen because it combines high quality earnings with a now debt free balance sheet after redeeming its senior notes in April 2026. This gives it more flexibility to fund silver focused growth projects. Earnings momentum has been very strong and margins currently look healthy, with net profit margin at 28.3% and return on equity at 18%. Management is investing in assets like Greens Creek and Keno Hill to support a higher silver production profile. At the same time, revenue is forecast to decline modestly over the next few years and the stock trades above one estimate of fair value, so investors may be paying a premium for this quality and growth optionality.

Debt free, high margin and focused on silver growth, Hecla’s story looks clean on the surface, but the real tension is between quality and price. Weigh the premium against the analysis report for Hecla Mining

Catalyst Pharmaceuticals (CPRX)

Overview: Catalyst Pharmaceuticals is a commercial biopharmaceutical company that develops and markets treatments for rare neurological and neuromuscular diseases in the United States, with a portfolio that includes Firdapse for LEMS, Fycompa for certain seizure types and AGAMREE for Duchenne muscular dystrophy.

Operations: Catalyst generates about US$597m in revenue from the development and commercialization of drug products, all from the United States.

Market Cap: US$3.82b

Catalyst Pharmaceuticals sits at an intersection for low-risk-focused investors, combining a rare disease portfolio with margins around 37% and cash generation, while also facing pressure from upcoming generic competition and a relatively thin late stage pipeline. Firdapse and AGAMREE are contributing to the business, supported by broader diagnosis and payer coverage, yet concentration in a few drugs and the recent loss of exclusivity for Fycompa mean future earnings are more exposed than the historical record suggests. The agreed US$31.50 per share cash acquisition by Angelini Pharma, alongside settlements that push potential Firdapse generics out to at least 2035 in some cases, adds an extra consideration that investors will want to weigh against these risks.

Accelerating rare disease cash flows, with US$597m in revenue and margins around 37%, can mask how concentrated Catalyst really is. Get the full story in the analysis report for Catalyst Pharmaceuticals, especially what happens if generics arrive sooner than expected.

Palantir Technologies (PLTR)

Overview: Palantir Technologies builds software that helps governments and companies make decisions from huge amounts of data, from defense and intelligence use cases to commercial applications in sectors like manufacturing, healthcare and agriculture. Its platforms, including Gotham, Foundry, Apollo and its Artificial Intelligence Platform, are used to integrate, analyze and deploy data driven tools across a wide range of real world operations.

Operations: Palantir generates about US$2.8b from Government customers and about US$2.5b from Commercial clients, with most revenue coming from the United States at roughly US$4.0b and additional contributions from the United Kingdom at about US$467.8m and the Rest of World at about US$782.7m.

Market Cap: US$328.8b

Palantir has caught investors’ attention because it combines very fast revenue and earnings growth with high profitability, including a 43.7% net margin and return on equity of 26.8%, while landing large US government and commercial AI contracts in areas as varied as defense, aerospace and agriculture. At the same time, the stock carries a very high P/E multiple and relies on external funding rather than deposits, which adds valuation and funding risk if sentiment turns or growth slows. With earnings forecast to grow 31.8% per year and U.S. commercial demand for its AI platform in focus, the key questions are how much of this potential is already priced in and how durable its edge is against rising AI competition.

Palantir’s rapid revenue growth, 43.7% net margin and 26.8% return on equity are impressive, but the real story is how sustainable that momentum looks next to its rich P/E multiple and rising AI competition, so walk through the analyst forecasts for Palantir Technologies to see what the market might be missing.

The three stocks covered here are only a starting point, and the full Low-Risk Leaders screener surfaced 64 more companies with similarly resilient balance sheets and low risk scores, each with its own narrative. Use Simply Wall St to identify and analyze the specific catalysts, balance sheet strength and risk factors that matter to you so you can focus on the ideas within this low risk group that best fit your approach.

Take Control of Your Investment Journey

If Hecla Mining or any of these companies have caught your attention, register for FREE with Simply Wall St and add your companies to a Watchlist to monitor the share price against the fair value and track any new developments as they happen. Once you've made your move, manage your holdings with our Portfolio Command Center that filters out the noise to deliver only the most critical, actionable updates. Throughout your journey, our Community allows you to filter the best ideas from thousands of investor perspectives. By uncovering hidden catalysts and risks early, you'll accelerate your decision-making and stay one step ahead of the market.

Curious About What Else You Might Be Missing?

Fresh opportunities can move from under the radar to full breakout fast, and the best entry points often vanish before the crowd catches on. Consider getting in early.

• Spot potential breakouts before momentum really starts by scanning a curated set of 51 high quality undervalued stocks that could reward investors who act while they are still under the radar for now.
• Shift your focus toward reliable cash returns with a hand picked group of 10 dividend fortresses built for investors who want income without chasing whatever is currently flying highest.
• Get ahead of the next wave in energy infrastructure with carefully selected 88 nuclear energy infrastructure stocks while the story is still forming and expectations have not yet caught up. Consider acting before conditions change.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.